Follow the AX1 share price and the full insider trade history of the company, a listed equity based in Australia. Shares trade on the AU market, under the authority of ASX. Operating in the Health Care sector, AX1 has logged 3 public disclosures. Market capitalisation: €405.8m. The latest transaction was disclosed on 16 June 2026 (Change in Substantial Holding). Among the most active insiders: Frasers Group plc (Company No. 06035106) (Frasers) and each of the persons listed in Annexure "A". Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
AX1 is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance healthcare.